Working to Eradicate Gynecologic Cancers

William C. Zamboni, PharmD

Associate Professor
University of North Carolina at Chapel Hill
101 Manning Drive
Chapel Hill, NC
USA 27514

Papers:
367 Phase I study of intravenous (IV) oxaliplatin and intraperitoneal (IP) docetaxel in recurrent ovarian and primary peritoneal cancer